Literature DB >> 11180886

Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan.

A Hasumi1, H Matsui, A Sugioka, I Uyama, Y Komori, J Fujita, H Aoki.   

Abstract

It is widely known that pancreaticobiliary maljunction (PBM), an anomalous arrangement of the pancreaticobiliary ductal system, is frequently associated with biliary tract cancer in patients with or without bile duct dilatation. In 1985, we surveyed patients with PBM who had been operated on at 133 Japanese institutions. A close relationship was shown between biliary tract carcinogenesis and PBM, according to the type of maljunction and age distribution: PBM patients with cystic dilatation had a high risk of bile duct cancer, even in those who were young (aged less than 20 years); the incidence of gallbladder cancer increased markedly in PBM patients over 40 years old with cystic dilatation, while it gradually increased with age in the PBM patients without cystic dilatation. Therefore, we recommend surgical treatment for patients with PBM even if they have no symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 11180886     DOI: 10.1007/s005340070003

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  13 in total

Review 1.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

Review 2.  Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.

Authors:  Takahiko Funabiki; Toshiki Matsubara; Shuichi Miyakawa; Shin Ishihara
Journal:  Langenbecks Arch Surg       Date:  2008-05-24       Impact factor: 3.445

3.  Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection.

Authors:  Dong Hun Kim; Dong Wook Choi; Seong Ho Choi; Jin Seok Heo
Journal:  Ann Surg Treat Res       Date:  2014-07-29       Impact factor: 1.859

4.  Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.

Authors:  Akihiko Tsuchida; Takao Itoi
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

5.  Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis.

Authors:  Takashi Muraki; Burcin Pehlivanoglu; Bahar Memis; Michelle D Reid; Takeshi Uehara; Olca Basturk; Jennifer Golia Pernicka; David S Klimstra; William R Jarnagin; Tetsuya Ito; Osamu Hasebe; Shinji Okaniwa; Naoto Horigome; Takeshi Hisa; Pardeep Mittal; Juan M Sarmiento; Shishir K Maithel; Jill Koshiol; Susan Tsai; Douglas Evans; Mert Erkan; Volkan Adsay
Journal:  Ann Surg       Date:  2020-11-12       Impact factor: 13.787

6.  Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case.

Authors:  Sae Murakami; Tetsuo Ajiki; Kimihiko Ueno; Hidehiro Sawa; Shinobu Tsuchida; Izuru Otsubo; Yuko Yoshida; Kenta Shinozaki; Taro Okazaki; Ippei Matsumoto; Takumi Fukumoto; Yonson Ku
Journal:  Surg Today       Date:  2013-04-12       Impact factor: 2.549

7.  Pancreaticobiliary Maljunctions in European Patients with Bile Duct Cysts: Results of the Multicenter Study of the French Surgical Association (AFC).

Authors:  Emilia Ragot; Jean-Yves Mabrut; Mehdi Ouaïssi; Alain Sauvanet; Safi Dokmak; Gennaro Nuzzo; Nermin Halkic; Remi Dubois; Christian Létoublon; Daniel Cherqui; Daniel Azoulay; Sabine Irtan; Karim Boudjema; François-René Pruvot; Jean-François Gigot; Reza Kianmanesh
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

8.  Metachronous Carcinomas of the Biliary Tract in a Patient Treated Three Times with Curative Surgery.

Authors:  Masanao Kurata; Atsutake Okamoto; Tomoyoshi Suzuki; Gaku Matsumoto; Koji Tsuruta; Goro Honda; Tetsuo Nemoto
Journal:  Case Rep Gastroenterol       Date:  2009-04-15

9.  A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.

Authors:  Kimberly B Higginbotham; Richard Lozano; Thomas Brown; Yehuda Z Patt; Takashi Arima; James L Abbruzzese; Melanie B Thomas
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-27       Impact factor: 4.553

10.  Self-expandable metallic stents for malignant biliary obstruction with an anomalous pancreaticobiliary junction.

Authors:  H Kogure; T Tsujino; H Yagioka; T Sasaki; Y Nakai; K Hirano; N Sasahira; H Isayama; M Tada; T Kawabe; M Omata
Journal:  Surg Endosc       Date:  2008-03       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.